- NCT00006244
Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma
Phase 2Completed - NCT00049712
Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma
Phase 1Completed - NCT00049699
VNP40101M in Treating Patients With Advanced or Metastatic Cancer
Phase 1Completed - NCT00049686
VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome
Phase 1Completed - NCT00049673
Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma
Phase 3Completed - NCT00049634
Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder
Phase 1Completed - NCT00049608
Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors
Phase 1Terminated - NCT00049582
Decitabine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Phase 1Terminated - NCT00049465
Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer
Not ApplicableCompleted - NCT00049452
Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer
Phase 3Completed - NCT00049400
S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction
Phase 1Completed - NCT00049374
Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 2Completed - NCT00049296
Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Phase 1Completed - NCT00049257
Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Phase 2Completed - NCT00049218
Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Phase 1Completed - NCT00049192
Oblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
Phase 2Completed - NCT00049179
S0117 Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
Phase 2Completed - NCT00049166
Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer
Phase 1Completed - NCT00049127
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Phase 1Completed - NCT00049075
Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia
Phase 2Completed - NCT00049062
Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer
Phase 2Completed - NCT00049023
Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
Phase 1Completed - NCT00048984
Diagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma
Completed - NCT00048971
Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
Completed - NCT00048958
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Active Not Recruiting - NCT00049231
EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical Cancer
Not ApplicableCompleted - NCT00026104
Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer
Phase 2Completed - NCT00047385
National Lung Screening Trial (NLST) Screening
Phase 3Completed - NCT00047346
Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction
Phase 1Completed - NCT00047333
Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed
Phase 2Terminated - NCT00047307
Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
Phase 1Completed - NCT00047281
Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma
Phase 2Completed - NCT00047255
Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer
Phase 3Completed - NCT00047242
UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00047229
Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
Phase 2Completed - NCT00047216
Tipifarnib in Treating Patients With Recurrent Bladder Cancer
Phase 2Completed - NCT00047203
Flavopiridol in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 2Completed - NCT00047190
Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia
Phase 2Completed - NCT00047060
Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome
Phase 1Completed - NCT00047047
Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00047034
E7389 in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00047008
Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
Phase 3Completed - NCT00046943
Atrasentan in Treating Patients With Prostate Cancer
Phase 3Completed - NCT00046917
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00021164
Vaccine Therapy in Treating Patients With Metastatic Cancer
Phase 2Completed - NCT00046904
Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer
Phase 3Completed - NCT00046865
Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast Cancer
Phase 3Completed - NCT00046826
Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy
Phase 2Completed - NCT00045734
Imatinib Mesylate in Treating Patients With Recurrent Meningioma
Phase 2Completed - NCT00045708
A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas
Phase 1Completed - NCT00045695
Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia
Phase 2Completed - NCT00045682
CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Phase 2Completed - NCT00045669
Imatinib Mesylate in Treating Patients With Salivary Gland Cancer
Phase 2Completed - NCT00045604
Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Phase 1Completed - NCT00045591
Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
Phase 2Terminated - NCT00045539
Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
Phase 2Completed - NCT00045526
Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer
Phase 2Completed - NCT00045513
Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma
Phase 1Completed - NCT00045500
UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma
Phase 1Completed - NCT00045487
Erlotinib in Treating Patients With Advanced Kidney Cancer
Phase 2Completed - NCT00045461
Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
Phase 2Unknown - NCT00045448
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00045422
Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
Phase 2Completed - NCT00045396
A Phase II Study Of The Farnesyltransferase Inhibitor ZANESTRA (R115777, NSC #702818, IND #58,359) In Complete Remission Following Induction And/Or Consolidation Chemotherapy In Adults With Poor-Risk Acute Myelogenous Leukemia (AML) And High-Risk Myelodysplasia (MDS)
Phase 2Completed - NCT00045370
Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Phase 1Completed - NCT00045331
Study in Predicting Outcome of Patients Undergoing Radiation Therapy for Prostate Cancer
Not ApplicableCompleted - NCT00045318
Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction
Phase 1Completed - NCT00045292
Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation
Phase 3Completed - NCT00045266
VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma
Phase 1Completed - NCT00045201
Erlotinib Hydrochloride and Irinotecan Hydrochloride in Treating Patients With Advanced Solid Tumors
Phase 1Active Not Recruiting - NCT00045188
Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer
Phase 2Completed - NCT00045175
UCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
Phase 1Completed - NCT00045162
S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer
Phase 3Completed - NCT00045110
Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma
Phase 1Completed - NCT00045097
Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Phase 2Completed - NCT00045045
Positron Emission Tomography in Detecting Testicle Cancer
Not ApplicableCompleted - NCT00045032
Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
Phase 3Completed - NCT00045006
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer
Phase 1Completed - NCT00044967
Genetic Study of Young Patients With Colorectal Cancer
Completed - NCT00030108
Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy
Phase 1Completed - NCT00030095
2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00033683
Combination Chemotherapy in Treating Women With Resected Breast Cancer
Phase 2Unknown - NCT00029003
Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase 2Completed - NCT00028977
Herbal Therapy in Treating Women With Metastatic Breast Cancer
Phase 1Completed - NCT00028951
Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva
Phase 3Completed - NCT00028912
Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Phase 1Completed - NCT00028899
Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
Phase 1Completed - NCT00028873
R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy
Phase 2Completed - NCT00028847
Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia
Phase 1Unknown - NCT00028821
2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00028782
EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer
Not ApplicableTerminated - NCT00028743
Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Phase 3Completed - NCT00028652
Interleukin-12 Gene Therapy in Treating Patients With Skin Metastases
Phase 1Terminated - NCT00028639
PS-341 in Treating Women With Metastatic Breast Cancer
Phase 2Completed - NCT00028587
PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00028561
BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors
Phase 1Terminated - NCT00028548
XK469 in Treating Patients With Advanced Solid Tumors
Phase 1Completed - NCT00028535
Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors
Phase 1Completed - NCT00028522
R(+)XK469 in Treating Patients With Advanced Neuroblastoma
Phase 1Completed - NCT00028509
Brain Function in Children Previously Treated on Clinical Trials POG-9605 and POG-9201
Completed